Genmab buys PDL Biopharma antibody plant for $240M

02/21/2008 | American City Business Journals

California-based PDL Biopharma completed the $240 million sale of its antibody manufacturing plant in Minnesota to Danish company Genmab A/S in a move to reduce its assets. The deal, which includes access to a leased development lab and other equipment, allows Genmab to supply clinical quantities of antibodies for PDL studies and retain the plant's 170 workers.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR